Sign In

Governor Hogan Appoints New Members to Maryland Life Sciences Advisory Board

​BALTIMORE, MD (January 13, 2016) – The Maryland Department of Commerce has a new slate of advisors supporting its activities to grow the biotechnology and health technology industry sectors in the state. Sixteen leaders from key federal, academic and industry organizations have been appointed by Governor Larry Hogan to the Maryland Life Sciences Advisory Board (LSAB).
 
“Maryland is a leading force in the development and commercialization of new and transformative technologies in the life sciences, an industry that is growing by leaps and bounds,” said Secretary of Commerce Mike Gill. “This group will bring together their diverse areas of expertise to help shape our strategy to accelerate the growth of Maryland’s biohealth and technology ecosystem.”
 
The LSAB was created by the state legislature in 2007 to assist in maintaining Maryland’s position as a leader in the life sciences industry. Comprised of 18 members, the Board includes the Secretary of Commerce, a representative designated by the Maryland Technology Development Corporation (TEDCO) and 16 members appointed by the Governor.   
 
The new appointees include a patient advocate, executives from global life sciences companies with U.S. headquarters in Maryland, small biotechnology companies, and leaders from the University of Maryland, University of Maryland Baltimore, Johns Hopkin University, Montgomery College, NIH, FDA and the U.S. Army Medical Research and Material Command. 
 
Daniel J. Abdun-Nabi, president and CEO of Gaithersburg-based Emergent BioSolutions will serve as the chairman of the LSAB.
 
"Maryland is recognized as a hot​bed for biotechnology innovation," said Abdun-Nabi. "It is an honor to be appointed by Governor Hogan as chair of the Maryland Life Sciences Advisory Board. I look forward to collaborating with other field experts to propel the industry forward with the goal of being at the forefront of cutting edge science and creating a positive health impact while stimulating the local economy and creating jobs."
 
A complete Roster of the Board members follows:
  • Daniel J. Abdun-Nabi, JD, LLM, President and CEO – Emergent BioSolutions Inc. (chair)
  • R. Michael Gill, Secretary – Maryland Department of Commerce
  • Robert Rosenbaum, President and Executive Director - TEDCO
  • Christopher P. Austin, M.D., Director, National Center for Advancing Translational Sciences – U.S. National Institutes of Health
  • Richard A. Bendis, President and CEO - BioHealth Innovation Inc. 
  • Jarrod Borkat, Head, External Collaborations, Biotech Hubs and Government Contracting - MedImmune
  • Marco A. Chacon, Ph.D., Founder, CEO and President - Paragon Bioservices, Inc.
  • Douglas Jon Liu, Senior Vice President, Head of Global Operations – Qiagen Sciences Inc.
  • Theodore J. Olsen, President and CEO - PathSensors, Inc.
  • Patrick G. O'Shea, Ph.D., Vice President and Chief Research Officer - University of Maryland 
  • Jay A. Perman, M.D., President - University of Maryland, Baltimore
  • Wendy Perrow, MBA, President and CEO - Alba Therapeutics Corporation
  • Karen L. Proudford, Ph.D., Associate Professor of Management and Director, Graves Honor Program – Earl G. Graves School of Business & Management Morgan State University and President, William E. Proudford Sickle Cell Fund, Inc.
  • Sanjay K. Rai, Ph.D., Chief Academic Officer and Senior Vice President for Academic Affairs - Montgomery College
  • David W. Smith, Ph.D., Vice President, Global Business Development, Emerging Technologies – Lonza Walkersville, Inc.
  • Col. Andrea Stahl, Ph.D., Director, MRMC CBRN Defense Medical Research Coordinating Office and JPC-Radiation Health Effects - U.S. Army Medical Research & Material Command
  • Frank F. Weichold, M.D., Ph.D., Director, Critical Path and Regulatory Science Initiatives, Office of the Commissioner – U.S. Food and Drug Administration
  • Christy Wyskiel, Senior Advisor to the President - Johns Hopkins Technology Ventures

Newly appointed Board members will serve until 2017.
 
About Maryland Commerce 
The Maryland Department of Commerce stimulates private investment and creates jobs by attracting new businesses, encouraging the expansion and retention of existing companies, and providing financial assistance to Maryland companies. The Department promotes the State's many economic advantages and markets local products and services at home and abroad to spur economic development and international investment, trade and tourism. Because they are major economic generators, the Department also supports the Arts, film production, sports and other special events. For more information, visit commerce.maryland.gov.
Close window
Close Disclaimer

Google Translate Disclaimer

The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology ​​​to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.